|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1999-5-17
|
|
pubmed:abstractText |
Carcinoma of the biliary system is a rare tumor entity, and patients with advanced disease face a dismal prognosis. Because of the absence of standard chemotherapy for advanced biliary carcinoma, we have performed two consecutive studies to evaluate the clinical potential of 5-fluorouracil, leucovorin and mitomycin C as well as the novel antimetabolite gemcitabine in this disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0030-2414
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
56
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
177-80
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:10202270-Adult,
pubmed-meshheading:10202270-Aged,
pubmed-meshheading:10202270-Antibiotics, Antineoplastic,
pubmed-meshheading:10202270-Antimetabolites, Antineoplastic,
pubmed-meshheading:10202270-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10202270-Biliary Tract Neoplasms,
pubmed-meshheading:10202270-Deoxycytidine,
pubmed-meshheading:10202270-Drug Administration Schedule,
pubmed-meshheading:10202270-Feasibility Studies,
pubmed-meshheading:10202270-Female,
pubmed-meshheading:10202270-Fluorouracil,
pubmed-meshheading:10202270-Humans,
pubmed-meshheading:10202270-Leucovorin,
pubmed-meshheading:10202270-Male,
pubmed-meshheading:10202270-Middle Aged,
pubmed-meshheading:10202270-Mitomycin,
pubmed-meshheading:10202270-Survival Analysis,
pubmed-meshheading:10202270-Treatment Outcome
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer.
|
|
pubmed:affiliation |
Department of Internal Medicine I, Division of Oncology, University of Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
